Anticardiolipin antibodies are associated with pulmonary arterial hypertension in Algerian systemic scleroderma patients
暂无分享,去创建一个
R. Djidjik | M. Ghaffor | A. Abdessemed | Yasmine Mellal | A. Tahiat | A. Ladjouze-Rezig | S. Boumedine
[1] S. Shankar,et al. Clinical significance of antiphospholipid antibodies in Indian scleroderma patients , 2009, Rheumatology International.
[2] I. Marie,et al. Anticardiolipin and anti‐β2 glycoprotein I antibodies and lupus‐like anticoagulant: prevalence and significance in systemic sclerosis , 2007, The British journal of dermatology.
[3] S. Migliaresi,et al. Clinical setting of patients with systemic sclerosis by serum autoantibodies , 1997, Clinical Rheumatology.
[4] A. Tincani,et al. More on anticardiolipin and anti-β2 glycoprotein I in systemic sclerosis , 2003, Annals of the rheumatic diseases.
[5] M. Fujimoto,et al. Measurement of anticardiolipin antibodies by ELISA using β2‐glycoprotein I (β2‐GPI) in systemic sclerosis , 1996 .
[6] K. Nishioka,et al. Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis. , 1990, Journal of the American Academy of Dermatology.
[7] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.